Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer According To Nih Study Services In Europe
9 services found
by:Genmab A/S based inCopenhagen V, DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments. Our research and innovation teams ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
by:RTI International based in, NORTH CAROLINA (USA)
Health research is our largest single field of study, encompassing research that ranges from studies of the human genome and the development of new drug compounds to national surveys of health behaviors and the implementation of global health programs. Building on our extensive research expertise and working with staff members at RTI Health Solutions, our commercial subsidiary, we form ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Leverage the widely used Nanostring platform to study gene expression in the tumor microenvironment, revealing biomarker signatures, mechanism of action, disease biology, and more. The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology insights for translational research and assesses the expression of 770 ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
To create powerful tools for cancer research and drug discovery, Creative Bioarray has launched various Tumor Cell Panels through integrating authenticated, well-characterized cell lines with mutation data from the Sanger Institute Catalogue of Somatic Mutations in Cancer (COSMIC). Each cell line is STR verified and mycoplasma tested, routinely run for research projects with a variety of small ...
by:Aiforia Technologies based inCambridge, MASSACHUSETTS (USA)
Bespoke AI models created for you: Whether you are looking to accelerate your preclinical analysis or scale your pathology services, you can now enhance your image analysis workflow with Aiforia. With our Custom AI Services Aiforia scientists build AI models for your specific needs. With AI you can automate manual image analysis tasks to save time and costs, standardize analysis across your whole ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
The goal of the French Kidney Cancer Research Network (Réseau Français de Recherche sur le Cancer du Rein) is to connect a National, multidisciplinary network of medical and scientific professionals who focus on therapeutic management and applied research into kidney cancer. Today, the UroCCR network includes 53 multidisciplinary clinical teams across France and Belgium. It is ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and optimized to interrogate the responses of your ...